Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009
'Frontiers in Medicinal Chemistry 2009' was organized as a joint German-Swiss meeting at the University of Heidelberg. It covered the areas of kinases and nuclear hormone receptors, inflammatory diseases, atherosclerosis and neuropsychiatry. Special sessions were dedicated to new...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | deu |
Published: |
Swiss Chemical Society
2009-09-01
|
Series: | CHIMIA |
Subjects: | |
Online Access: | https://www.chimia.ch/chimia/article/view/4711 |
_version_ | 1819278248833449984 |
---|---|
author | Werner Neidhart Hans Peter Märki Peter Mohr |
author_facet | Werner Neidhart Hans Peter Märki Peter Mohr |
author_sort | Werner Neidhart |
collection | DOAJ |
description |
'Frontiers in Medicinal Chemistry 2009' was organized as a joint German-Swiss meeting at the University of Heidelberg. It covered the areas of kinases and nuclear hormone receptors, inflammatory diseases, atherosclerosis and neuropsychiatry. Special sessions were dedicated to new technologies
in nanomedicine, proteomics and drug targeting. A session on highlights in medicinal chemistry completed the program. The lectures covered a broad range of interdisciplinary topics including molecular design and lead optimization programs, development and application of new technologies in
proteomics, drug delivery & chemical synthesis.
|
first_indexed | 2024-12-24T00:09:00Z |
format | Article |
id | doaj.art-4b5a01f307974dc9983cc58e95a86db5 |
institution | Directory Open Access Journal |
issn | 0009-4293 2673-2424 |
language | deu |
last_indexed | 2024-12-24T00:09:00Z |
publishDate | 2009-09-01 |
publisher | Swiss Chemical Society |
record_format | Article |
series | CHIMIA |
spelling | doaj.art-4b5a01f307974dc9983cc58e95a86db52022-12-21T17:24:55ZdeuSwiss Chemical SocietyCHIMIA0009-42932673-24242009-09-0163910.2533/chimia.2009.573Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009Werner NeidhartHans Peter MärkiPeter Mohr 'Frontiers in Medicinal Chemistry 2009' was organized as a joint German-Swiss meeting at the University of Heidelberg. It covered the areas of kinases and nuclear hormone receptors, inflammatory diseases, atherosclerosis and neuropsychiatry. Special sessions were dedicated to new technologies in nanomedicine, proteomics and drug targeting. A session on highlights in medicinal chemistry completed the program. The lectures covered a broad range of interdisciplinary topics including molecular design and lead optimization programs, development and application of new technologies in proteomics, drug delivery & chemical synthesis. https://www.chimia.ch/chimia/article/view/4711AtherosclerosisDrug targetingHighlights in medicinal chemistryInflammatory diseasesKinasesNanomedicine |
spellingShingle | Werner Neidhart Hans Peter Märki Peter Mohr Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009 CHIMIA Atherosclerosis Drug targeting Highlights in medicinal chemistry Inflammatory diseases Kinases Nanomedicine |
title | Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009 |
title_full | Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009 |
title_fullStr | Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009 |
title_full_unstemmed | Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009 |
title_short | Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009 |
title_sort | frontiers in medicinal chemistry joint german swiss meeting on medicinal chemistry heidelberg germany march 15 18 2009 |
topic | Atherosclerosis Drug targeting Highlights in medicinal chemistry Inflammatory diseases Kinases Nanomedicine |
url | https://www.chimia.ch/chimia/article/view/4711 |
work_keys_str_mv | AT wernerneidhart frontiersinmedicinalchemistryjointgermanswissmeetingonmedicinalchemistryheidelberggermanymarch15182009 AT hanspetermarki frontiersinmedicinalchemistryjointgermanswissmeetingonmedicinalchemistryheidelberggermanymarch15182009 AT petermohr frontiersinmedicinalchemistryjointgermanswissmeetingonmedicinalchemistryheidelberggermanymarch15182009 |